Flomerics Group PLC
04 May 2005
Flomerics Group PLC
4 May 2005
Grant of Options
Flomerics Group plc ("the Company") announces that it has made the following
grants of options to directors of the Company:
Name Date of grant Number of Ordinary Exercise price Total number of
Shares of 1p each shares under option
under option
David Tatchell 3 May 2005 60,000 70p 161,250
Chris Ogle 3 May 2005 35,000 70p 201,250
Gary Carter 3 May 2005 100,000 70p 100,000
The options granted on 3 May 2005 and outlined above are exercisable at any time
from 3 May 2008 expiring on 2 May 2015.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.